Preventive effect of mesenteric traction syndrome by intravenous administration of flurbiprofen axetil in cesarean section

Preventive effect of mesenteric traction syndrome by intravenous administration of flurbiprofen axetil in cesarean section - Preventive effect of mesenteric traction syndrome by intravenous administration of flurbiprofen axetil in cesarean section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048789

Enrollment

Registered

2022-08-30

Start date

2022-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective caesarean section

Interventions

Flurbiprofen axetil 50 mg IV non-administered

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing elective caesarean section

Exclusion criteria

Exclusion criteria: Less than 37 weeks of gestation, multiple births, fetal growth restriction, pregnancy hypertension syndrome, renal dysfunction, heart disease complications, NSAID allergy history, history of aspirin asthma, post-uterine surgery

Design outcomes

Primary

Measure	Time frame
Presence or absence of MTS	—

Countries

Japan

Contacts

Public Contactmaiko suzuki

Minaminagano Medical Center, Sinonoi General Hospital Department of Anesthesiology

maiko.m.1106@gmail.com026-292-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026